Objective: To compare the cost, efficacy and cost efficacy of tazobactam/ piperacillin and imipenem/cilastatin in the …/day) and imipenem/cilastatin (total daily dosage of 1.5 to 4 g/day). The mean duration of treatment varied from 5.5 to 8.2 days … for tazobactam/piperacillin and 5 to 9.4 days for imipenem/cilastatin. Main outcome measure and results: Compared with …

(CIP/MTZ IV/PO) with that of IV ciprofloxacin plus IV metronidazole (CIP/MTZ IV) and IV imipenem-cilastatin (IMI IV) in … plus metronidazole was cost effective compared with full IV courses of ciprofloxacin plus metronidazole or imipenem-cilastatin …. In patients unable to receive oral therapy, no difference in mean cost was found between IV imipenem-cilastatin or IV …

, with possibly fewer gastrointestinal and CNS tolerability problems than imipenem/cilastatin. Therefore, meropenem is likely …/day consistently demonstrated similar efficacy to other regimens (imipenem/ cilastatin, ceftazidime with or without amikacin) commonly …

in serious infections. Its therapeutic efficacy in a wide range of serious infections is similar to that of imipenem/cilastatin … imipenem/cilastatin, by rapid intravenous bolus injection results in lower drug administration costs than with the standard … imipenem/cilastatin have similar acquisition costs, the option of administering meropenem by bolus injection and its lower …